Enantios raises €1.9M Seed round

The funding will advance its technology, support hiring, and strengthen partnerships, positioning Enantios as a leader in scientific innovation. Specifically, it will be used for technology development and enhancement, talent acquisition, and strategic partnerships with pharmaceutical companies, academic institutions, and research organizations.

Source: https://www.venturekick.ch/ETH-Zurich-spin-off-Enantios-secures-over-CHF-18M-in-Seed-funding-to-innovate-complex-molecule-characterization